Abdominal CT to Predict the Risk of Acute Graft-versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation

NCT02117115 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

21

Enrollment

OTHER

Sponsor class

Conditions

Myelodysplastic Syndromes
Leukemia, Myeloid, Acute
Leukemia, Myelogenous, Chronic
Multiple Myeloma

Interventions

RADIATION: Dynamic contrast-enhanced computed tomography
DRUG: Ioversol

Sponsor

Washington University School of Medicine